시장보고서
상품코드
1975299

심혈관 디지털 솔루션 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Cardiovascular Digital Solutions Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 170 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심혈관 디지털 솔루션 시장 규모는 2025년 1,320억 5,000만 달러에서 2026년부터 2034년까지 CAGR 6.04%로 성장하여 2034년에는 2,238억 6,000만 달러에 달할 것으로 예측됩니다.

세계 심혈관 디지털 솔루션 시장은 심혈관질환의 유병률 증가와 원격 환자 모니터링에 대한 수요 증가로 인해 빠르게 성장하고 있습니다. 웨어러블 기기, AI 기반 진단 기술, 원격 심전도 플랫폼 등 디지털 헬스 기술이 심장 의료 제공 방식을 변화시키고 있습니다. 의료기관에서는 조기 진단의 정확도 향상, 환자 예후 개선, 입원율 감소를 목적으로 디지털 도구의 도입이 가속화되고 있습니다.

의료의 디지털화 진전, 정부의 지원 정책, 클라우드 기반 의료 인프라의 발전이 주요 성장 요인입니다. 가치 기반 의료와 맞춤형 치료로의 전환은 데이터 기반 심혈관 관리 솔루션에 대한 수요를 가속화하고 있습니다. 또한, 스마트폰의 보급률 증가와 인터넷 연결성 향상으로 인해 디지털 심장 모니터링 애플리케이션의 광범위한 도입이 촉진되고 있습니다.

향후 전망으로는 인공지능(AI), 빅데이터 분석, 예측 모델링의 통합이 시장의 발전을 형성하는 데 중요한 역할을 할 것입니다. 웨어러블 심장 장치와 상호 운용 가능한 헬스케어 플랫폼의 지속적인 혁신은 의료 협력 강화에 기여할 것으로 기대됩니다. 의료 시스템이 예방 의료를 우선시하는 가운데, 디지털 심혈관 솔루션은 장기적으로 환자 관리를 개선하고 전 세계 질병 부담을 줄이는 데 있어 핵심적인 역할을 계속할 것입니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 심혈관 디지털 솔루션 시장 : 서비스 유형별

제5장 세계의 심혈관 디지털 솔루션 시장 : 구성요소별

제6장 세계의 심혈관 디지털 솔루션 시장 : 전개 방식별

제7장 세계의 심혈관 디지털 솔루션 시장 : 최종사용자별

제8장 세계의 심혈관 디지털 솔루션 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

KSM 26.04.03

The Cardiovascular Digital Solutions Market size is expected to reach USD 223.86 Billion in 2034 from USD 132.05 Billion (2025) growing at a CAGR of 6.04% during 2026-2034.

The Global Cardiovascular Digital Solutions Market is expanding rapidly due to the increasing prevalence of cardiovascular diseases and the growing need for remote patient monitoring. Digital health technologies, including wearable devices, AI-based diagnostics, and telecardiology platforms, are transforming cardiac care delivery. Healthcare providers are increasingly adopting digital tools to enhance early diagnosis, improve patient outcomes, and reduce hospitalization rates.

Rising healthcare digitization, supportive government initiatives, and advancements in cloud-based healthcare infrastructure are key growth drivers. The shift toward value-based care and personalized treatment approaches has accelerated demand for data-driven cardiovascular management solutions. Additionally, increasing smartphone penetration and improved internet connectivity are facilitating broader adoption of digital cardiac monitoring applications.

Looking forward, integration of artificial intelligence, big data analytics, and predictive modeling will play a crucial role in shaping the market's evolution. Continuous innovation in wearable cardiac devices and interoperable health platforms is expected to enhance care coordination. As healthcare systems prioritize preventive care, digital cardiovascular solutions will remain central to improving long-term patient management and reducing global disease burden.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service Type

  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs

By Components

  • Devices
  • Software

By Deployment Type

  • Cloud-Based/Web-Based
  • On-Premise

By End User

  • Homecare Settings
  • Ambulatory Care Centers
  • Hospitals
  • Clinics

COMPANIES PROFILED

  • Apple Inc, Medtronic plc, GE HealthCare Technologies Inc, Optum Inc, Koninklijke Philips NV, Baxter International Inc, Verily Life Sciences LLC, iRhythm Technologies Inc, AliveCor Inc, HeartFlow Inc, Bardy Diagnostics Inc, Nanowear Inc, Cardiac Insight Inc, EviCore healthcare, Cardiotrack
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Service Type
  • 4.2. Unobtrusive Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. CVD Health Informatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Cardiac Rehab Programs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET: BY COMPONENTS 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Components
  • 5.2. Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET: BY DEPLOYMENT TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Deployment Type
  • 6.2. Cloud-Based/Web-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Service Type
    • 8.2.2 By Components
    • 8.2.3 By Deployment Type
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Service Type
    • 8.3.2 By Components
    • 8.3.3 By Deployment Type
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Service Type
    • 8.4.2 By Components
    • 8.4.3 By Deployment Type
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Service Type
    • 8.5.2 By Components
    • 8.5.3 By Deployment Type
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Service Type
    • 8.6.2 By Components
    • 8.6.3 By Deployment Type
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Apple Inc
    • 10.2.2 Medtronic Plc
    • 10.2.3 GE HealthCare Technologies Inc
    • 10.2.4 Optum Inc
    • 10.2.5 Koninklijke Philips N.V
    • 10.2.6 Baxter International Inc
    • 10.2.7 Verily Life Sciences LLC
    • 10.2.8 IRhythm Technologies Inc
    • 10.2.9 AliveCor Inc
    • 10.2.10 HeartFlow Inc
    • 10.2.11 Bardy Diagnostics Inc
    • 10.2.12 Nanowear Inc
    • 10.2.13 Cardiac Insight Inc
    • 10.2.14 EviCore Healthcare
    • 10.2.15 Cardiotrack
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제